Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 145

1.

A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells.

West RB, Rubin BP, Miller MA, Subramanian S, Kaygusuz G, Montgomery K, Zhu S, Marinelli RJ, De Luca A, Downs-Kelly E, Goldblum JR, Corless CL, Brown PO, Gilks CB, Nielsen TO, Huntsman D, van de Rijn M.

Proc Natl Acad Sci U S A. 2006 Jan 17;103(3):690-5. Epub 2006 Jan 6.

PMID:
16407111
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Translocation and expression of CSF1 in pigmented villonodular synovitis, tenosynovial giant cell tumor, rheumatoid arthritis and other reactive synovitides.

Cupp JS, Miller MA, Montgomery KD, Nielsen TO, O'Connell JX, Huntsman D, van de Rijn M, Gilks CB, West RB.

Am J Surg Pathol. 2007 Jun;31(6):970-6.

PMID:
17527089
[PubMed - indexed for MEDLINE]
3.

Molecular identification of COL6A3-CSF1 fusion transcripts in tenosynovial giant cell tumors.

Möller E, Mandahl N, Mertens F, Panagopoulos I.

Genes Chromosomes Cancer. 2008 Jan;47(1):21-5.

PMID:
17918257
[PubMed - indexed for MEDLINE]
4.

Treatment of tenosynovial giant cell tumor and pigmented villonodular synovitis.

Ravi V, Wang WL, Lewis VO.

Curr Opin Oncol. 2011 Jul;23(4):361-6. doi: 10.1097/CCO.0b013e328347e1e3. Review.

PMID:
21577109
[PubMed - indexed for MEDLINE]
5.

Molecular pathways involved in synovial cell inflammation and tumoral proliferation in diffuse pigmented villonodular synovitis.

Fiocco U, Sfriso P, Lunardi F, Pagnin E, Oliviero F, Scagliori E, Cozzi L, Vezzù M, Molena B, Scanu A, Panziera C, Nardacchione R, Rubaltelli L, Dayer JM, Calabrese F, Punzi L.

Autoimmun Rev. 2010 Sep;9(11):780-4. doi: 10.1016/j.autrev.2010.07.001. Epub 2010 Jul 8. Review.

PMID:
20620241
[PubMed - indexed for MEDLINE]
6.

Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis.

Cassier PA, Gelderblom H, Stacchiotti S, Thomas D, Maki RG, Kroep JR, van der Graaf WT, Italiano A, Seddon B, Dômont J, Bompas E, Wagner AJ, Blay JY.

Cancer. 2012 Mar 15;118(6):1649-55. doi: 10.1002/cncr.26409. Epub 2011 Aug 5.

PMID:
21823110
[PubMed - indexed for MEDLINE]
Free Article
7.

Immunohistochemical and biogenetic features of diffuse-type tenosynovial giant cell tumors: the potential roles of cyclin A, P53, and deletion of 15q in sarcomatous transformation.

Huang HY, West RB, Tzeng CC, van de Rijn M, Wang JW, Chou SC, Huang WW, Eng HL, Lin CN, Yu SC, Wu JM, Lu CC, Li CF.

Clin Cancer Res. 2008 Oct 1;14(19):6023-32. doi: 10.1158/1078-0432.CCR-08-0252.

PMID:
18829481
[PubMed - indexed for MEDLINE]
Free Article
8.

Molecular cytogenetic mapping of recurrent chromosomal breakpoints in tenosynovial giant cell tumors.

Nilsson M, Höglund M, Panagopoulos I, Sciot R, Dal Cin P, Debiec-Rychter M, Mertens F, Mandahl N.

Virchows Arch. 2002 Nov;441(5):475-80. Epub 2002 Apr 13.

PMID:
12447678
[PubMed - indexed for MEDLINE]
9.

Diffuse and localized tenosynovial giant cell tumor and pigmented villonodular synovitis: a clinicopathologic and flow cytometric DNA analysis.

Abdul-Karim FW, el-Naggar AK, Joyce MJ, Makley JT, Carter JR.

Hum Pathol. 1992 Jul;23(7):729-35.

PMID:
1319390
[PubMed - indexed for MEDLINE]
10.

Giant cell tumor of tendon sheath, tenosynovial giant cell tumor, and pigmented villonodular synovitis: defining the presentation, surgical therapy and recurrence.

Martin RC 2nd, Osborne DL, Edwards MJ, Wrightson W, McMasters KM.

Oncol Rep. 2000 Mar-Apr;7(2):413-9. Review.

PMID:
10671695
[PubMed - indexed for MEDLINE]
11.

Chromosome aberrations in tenosynovial giant cell tumors and nontumorous synovial tissue.

Mertens F, Orndal C, Mandahl N, Heim S, Bauer HF, Rydholm A, Tufvesson A, Willén H, Mitelman F.

Genes Chromosomes Cancer. 1993 Apr;6(4):212-7. Review.

PMID:
7685623
[PubMed - indexed for MEDLINE]
12.

Reassignment of the human CSF1 gene to chromosome 1p13-p21.

Morris SW, Valentine MB, Shapiro DN, Sublett JE, Deaven LL, Foust JT, Roberts WM, Cerretti DP, Look AT.

Blood. 1991 Oct 15;78(8):2013-20.

PMID:
1912583
[PubMed - indexed for MEDLINE]
Free Article
13.

Malignant giant cell tumor of synovium (malignant pigmented villonodular synovitis).

Layfield LJ, Meloni-Ehrig A, Liu K, Shepard R, Harrelson JM.

Arch Pathol Lab Med. 2000 Nov;124(11):1636-41. Review.

PMID:
11079016
[PubMed - indexed for MEDLINE]
14.

Tenosynovial giant cell tumor: case report and review.

Lucas DR.

Arch Pathol Lab Med. 2012 Aug;136(8):901-6. doi: 10.5858/arpa.2012-0165-CR. Review.

PMID:
22849738
[PubMed - indexed for MEDLINE]
15.

Diffuse-variant tenosynovial giant cell tumor: a rare and aggressive lesion.

Rowlands CG, Roland B, Hwang WS, Sevick RJ.

Hum Pathol. 1994 Apr;25(4):423-5.

PMID:
8163276
[PubMed - indexed for MEDLINE]
16.

Diffuse tenosynovial giant cell tumor of soft tissues. Report of a case with cytologic and cytogenetic findings.

González-Cámpora R, Salas Herrero E, Otal-Salaverri C Villar-Rodriguez JL, San Martín Díez V, Hevia Vazquez A, Galera Davidson H.

Acta Cytol. 1995 Jul-Aug;39(4):770-6.

PMID:
7631554
[PubMed - indexed for MEDLINE]
17.

The macrophage colony-stimulating factor 1 response signature in breast carcinoma.

Beck AH, Espinosa I, Edris B, Li R, Montgomery K, Zhu S, Varma S, Marinelli RJ, van de Rijn M, West RB.

Clin Cancer Res. 2009 Feb 1;15(3):778-87. doi: 10.1158/1078-0432.CCR-08-1283.

PMID:
19188147
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Multinucleated cells in pigmented villonodular synovitis and giant cell tumor of tendon sheath express features of osteoclasts.

Darling JM, Goldring SR, Harada Y, Handel ML, Glowacki J, Gravallese EM.

Am J Pathol. 1997 Apr;150(4):1383-93.

PMID:
9094994
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

[Tenosynovial giant cell tumor].

Kuhnen C, Müller KM, Rabstein S, Kasprzynski A, Herter P.

Pathologe. 2005 Mar;26(2):96-110. German.

PMID:
15657685
[PubMed - indexed for MEDLINE]
20.

Coordinate expression of colony-stimulating factor-1 and colony-stimulating factor-1-related proteins is associated with poor prognosis in gynecological and nongynecological leiomyosarcoma.

Espinosa I, Beck AH, Lee CH, Zhu S, Montgomery KD, Marinelli RJ, Ganjoo KN, Nielsen TO, Gilks CB, West RB, van de Rijn M.

Am J Pathol. 2009 Jun;174(6):2347-56. doi: 10.2353/ajpath.2009.081037. Epub 2009 May 14.

PMID:
19443701
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk